Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients
Status:
Terminated
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase II study is to determine the feasibility of the dose titration and
assessment protocol in the impatient population, in the clinical setting of preventing or
managing breakthrough pain, before conducting an appropriately powered phase III study. Thus
the primary purpose of this study is to determine the proportion of patients who are
successfully titrated to an effective dose of sublingual methadone.